File Download
Patent History
- ApplicationEP 20100791704 2010-06-21
- PublicationEP 2445859 2012-05-02
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: METHOD FOR ISOLATING CIMIRACEMATE A
Title | METHOD FOR ISOLATING CIMIRACEMATE A |
---|---|
Priority Date | 2010-06-21 PCT/IB2010001772 2009-06-21 US 12/218962P |
Inventors | |
Issue Date | 30-Nov-2012 |
Citation | EP Published Patent application EP 2445859. European Patent Office (EPO), Escapenet, 2012 How to Cite? |
Abstract | The subject invention provides a method for optimal isolation of cimiracemate A for subsequent use as a therapeutic agent or dietary supplement in single entry or in combination with other treatment modalities. In addition, the subject invention discloses cimiracemate A as a bioactive marker that can be used to identify the members of the Cimicifuga genus for example: C. racemosa, C. dahitrica (Turcz.) Maxim., C. foetida L., and C. heracleifolia Kom. The bioactive marker cimiracemate A can also be used to standardize the extracts of C. racemosa as anti-inflammatory agents for the treatment of inflammatory conditions associated with diseases and syndromes including, for example, rheumatism, stroke, myocarditis, atherosclerosis, infectious diseases, allergy and related autoimmune diseases. |
Persistent Identifier | http://hdl.handle.net/10722/176770 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2012-11-30T08:38:27Z | - |
dc.date.available | 2012-11-30T08:38:27Z | - |
dc.date.issued | 2012-11-30 | - |
dc.identifier.citation | EP Published Patent application EP 2445859. European Patent Office (EPO), Escapenet, 2012 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/176770 | - |
dc.description.abstract | The subject invention provides a method for optimal isolation of cimiracemate A for subsequent use as a therapeutic agent or dietary supplement in single entry or in combination with other treatment modalities. In addition, the subject invention discloses cimiracemate A as a bioactive marker that can be used to identify the members of the Cimicifuga genus for example: C. racemosa, C. dahitrica (Turcz.) Maxim., C. foetida L., and C. heracleifolia Kom. The bioactive marker cimiracemate A can also be used to standardize the extracts of C. racemosa as anti-inflammatory agents for the treatment of inflammatory conditions associated with diseases and syndromes including, for example, rheumatism, stroke, myocarditis, atherosclerosis, infectious diseases, allergy and related autoimmune diseases. | en_HK |
dc.title | METHOD FOR ISOLATING CIMIRACEMATE A | en_HK |
dc.type | Patent | en_US |
dc.description.nature | published_or_final_version | en_US |
dc.contributor.inventor | Yang, Lai Hung, Cindy | en_HK |
dc.contributor.inventor | Lau, ASY | en_HK |
patents.identifier.application | EP 20100791704 | en_HK |
patents.description.assignee | PURAPHARM INTERNAT HK LTD [CN]; VERSITECH LTD [CN] | en_HK |
patents.description.country | European Patent Office | en_HK |
patents.date.publication | 2012-05-02 | en_HK |
patents.date.application | 2010-06-21 | en_HK |
patents.date.priority | 2010-06-21 PCT/IB2010001772 | en_HK |
patents.date.priority | 2009-06-21 US 12/218962P | en_HK |
patents.description.cc | EP | en_HK |
patents.identifier.publication | EP 2445859 | en_HK |
patents.relation.family | AU 2010264200 (A1) 2012-01-19 | en_HK |
patents.relation.family | CA 2766002 (A1) 2010-12-29 | en_HK |
patents.relation.family | CN 102625791 (A) 2012-08-01 | en_HK |
patents.relation.family | EP 2445859 (A2) 2012-05-02 | en_HK |
patents.relation.family | US 2012190882 (A1) 2012-07-26 | en_HK |
patents.relation.family | WO 2010150102 (A2) 2010-12-29 | en_HK |
patents.description.kind | A2 | en_HK |
patents.type | Patent_published | en_HK |